中信證券(600030.SH):擬使用不超80億元暫時閒置A股配股募集資金開展現金管理
格隆匯2月8日丨中信證券(600030.SH)公佈,公司於2022年2月8日召開第七屆董事會第三十五次會議、第七屆監事會第十三次會議,審議通過了《關於利用暫時閒置A股募集資金開展現金管理的議案》,同意公司使用不超過人民幣80億元(含80億元)的暫時閒置A股配股募集資金開展現金管理,投資安全性高、流動性好、投資期限不超過12個月的投資產品,包括銀行大額存單、定期存款、結構性存款、約期存款、銀行理財產品。自董事會審議通過之日起一年內該項資金額度可循環滾動使用。公司董事會授權經營管理層在授權額度範圍內行使該項投資決策權並簽署相關合同文件,公司總司庫負責組織實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.